pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,899 catalysts · 6,552 phase readout · 2,341 8k filing · 388 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-17: 0 catalysts2026-08-18: 0 catalysts2026-08-19: 30 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout6,552
  • 8k filing2,341
  • earnings388
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT07708831: Trial on Single/Multiple Ascending Doses for Safety, PK and PD for CBP-0276 in Healthy Subjects

Sponsor: Clarent Biopharma, Inc.. Phase: PHASE1. Conditions: Healthy Volunteers

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04692831: Testing a New Imaging Agent to Identify Cancer

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE1. Conditions: HER-2 Positive Malignant Carcinoma of Breast, HER-2 Protein Overexpression, HER2-positive Metastatic Breast Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03612531: Manual Therapy in Treating Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors

Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Cancer Survivor, Dysphagia, Fibrosis, Head and Neck Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT06092502: Shoulder Impingement Syndrome and Graded Motor Imagery

Sponsor: Nuray Alaca. Phase: NA. Conditions: Shoulder Pain, Shoulder Impingement Syndrome

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07445802: Medication Adherence in Severe Mental Illness: a Promotion Program

Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz. Phase: NA. Conditions: Treatment Adherence and Compliance, Severe Mental Disorders, Bipolar Disorder (BD), Schizophrenia Disorder

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07733453: Baerveldt Versus Paul Study

Sponsor: University of Sydney. Phase: PHASE4. Conditions: Glaucoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07158853: Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder

Sponsor: University of Minnesota. Phase: PHASE1. Conditions: Opioid Use Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT07347353: Molecular HistoMx Assessment for Kidney Transplant Rejection and Management

Sponsor: Paris Translational Research Center for Organ Transplantation. Phase: . Conditions: Graft Rejection

full page →ctgov ↗
›RECRUITINGphase readoutNCT07386353: Intrathecal Versus Epidural Morphine for Post-Cesarean Analgesia

Sponsor: Hospital Central do Funchal. Phase: PHASE4. Conditions: Analgesia Obstetrical, Analgesia, Post Operative Pain, Patient Satisfaction, Cesarean Section Pain

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07655453: Early Clinical Study on the Safety, Tolerability, Pharmacokinetics, and Efficacy of STR-P005

Sponsor: Starna Therapeutics. Phase: NA. Conditions: Relapsed/Refractory Autoimmune Diseases

full page →ctgov ↗
›COMPLETEDphase readoutNCT07757737: Impact of Exoskeleton Use on Perceived Effort and Pain During Resident Handling in Nursing Home Care Staff

Sponsor: LNA SANTE. Phase: . Conditions: Musculoskeletal Diseases, Occupational Diseases, Low Back Pain, Occupational Health

full page →ctgov ↗
›RECRUITINGphase readoutNCT06469437: The Impact of Geriatric Assessment on the Treatment Plan of Elderly Patients With T2DM

Sponsor: Hospital de Clinicas de Porto Alegre. Phase: NA. Conditions: Type2diabetes, Frail Elderly Syndrome, Frailty, Geriatric Assessment

full page →ctgov ↗
›COMPLETEDphase readoutNCT03944837: Acute Maternal Hyperoxygenation in CHD

Sponsor: The Hospital for Sick Children. Phase: NA. Conditions: Congenital Heart Disease

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07497724: Odevixibat Outcomes in Patients With PFIC Versus an External Control Cohort (OvEC-PFIC)

Sponsor: Ipsen. Phase: . Conditions: PFIC - Progressive Familial Intrahepatic Cholestasis

full page →ctgov ↗
›RECRUITINGphase readoutNCT04682223: Telerehabilitation for Aphasia (TERRA)

Sponsor: University of South Carolina. Phase: NA. Conditions: Aphasia, Stroke, Stroke Rehabilitation

full page →ctgov ↗
›RECRUITINGphase readoutNCT03773159: Development of a Device for Evaluating Primary Hemostasis Under Whole Blood Flow Conditions

Sponsor: Centre Hospitalier Universitaire Dijon. Phase: . Conditions: Von Willebrand Diseases, Major Constitutional Thrombopathy, Patient on Antiplatelet Drugs

full page →ctgov ↗
›RECRUITINGphase readoutNCT07018180: Interventional Clinical Trial Evaluating COVER PATCH CAPTEUR PROTECT Support Solutions for Continuous Glucose Monitoring Sensors in Patients With Diabetes

Sponsor: CAPTEUR PROTECT. Phase: NA. Conditions: Diabetes

full page →ctgov ↗
›COMPLETEDphase readoutNCT07320859: Comparing Mirror and Music for Dialysis Needle Pain

Sponsor: Izmir Kavram Vocational School. Phase: NA. Conditions: Chronic Kidney Disease, Pain, Procedural, Arteriovenous Fistula

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07714759: A Study Comparing Continuous Glucose Monitoring Augmented Nutritional Counseling and Standard of Care Treatment Strategies in a Three-Month Nutrition Intervention

Sponsor: University of Florida. Phase: NA. Conditions: Obesity & Overweight, Obese Adolescents, Metabolic Abnormalities

full page →ctgov ↗
›RECRUITINGphase readoutNCT06309979: A Study to Assess Growth in Children With Idiopathic Short Stature

Sponsor: BioMarin Pharmaceutical. Phase: . Conditions: Idiopathic Short Stature

full page →ctgov ↗
›COMPLETEDphase readoutNCT02360579: Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma

Sponsor: Iovance Biotherapeutics, Inc.. Phase: PHASE2. Conditions: Metastatic Melanoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT04700579: Pre- and Post-treatment Lung Microbiota, Metabolome and Immune Signatures at the Site of Disease in Patients With Active Pulmonary Tuberculosis

Sponsor: University of Stellenbosch. Phase: . Conditions: TB - Tuberculosis, HIV/AIDS

full page →ctgov ↗
›RECRUITINGphase readoutNCT03667196: Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of Percutaneous Coronary Intervention for Chronic Total Occlusions

Sponsor: Seung-Whan Lee, M.D., Ph.D.. Phase: . Conditions: Chronic Total Occlusion of Coronary Artery

full page →ctgov ↗
›RECRUITINGphase readoutNCT05216679: Novel Stretching Device Versus Night Splints

Sponsor: SAE Orthopedics. Phase: NA. Conditions: Plantar Fasciitis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06584396: Evaluating Mechanical Properties of Post-Mastectomy Skin Flaps to Estimate Reconstruction Risks, the EMPOWER Study

Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Breast Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT05023096: Potential Effects of Electronic Nicotine Delivery System Flavor Regulations on African American Menthol Smokers

Sponsor: Virginia Commonwealth University. Phase: NA. Conditions: Electronic Nicotine Delivery System Flavors

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06275724: Specified Drug-use Survey of Leqvio for s.c. Injection.

Sponsor: Novartis Pharmaceuticals. Phase: . Conditions: Familial Hypercholesterolaemia, Hypercholesterolaemia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07327723: Effects of Repetitive Peripheral Magnetic Stimulation(rPMS) on CTS(Carpal Tunnel Syndrome)

Sponsor: Ankara University. Phase: NA. Conditions: Carpal Tunnel Syndrome (CTS)

full page →ctgov ↗
›RECRUITINGphase readoutNCT05373823: MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors

Sponsor: Rutgers, The State University of New Jersey. Phase: NA. Conditions: Melanoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06543823: SUPRATHEL 250 as a Treatment for Oropharyngeal Wounds

Sponsor: Alaa Emara. Phase: NA. Conditions: Tonsillitis, Tonsillectomy, Tonsillitis Recurrent

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07240259: Feasibility of Tracheobronchial Reconstruction Using Allogenic Aortic Patch in Children

Sponsor: National Taiwan University Hospital. Phase: NA. Conditions: Trachea Diseases, Tracheal Stenosis, Tuberculosis; Tracheitis, Airway Disease, Tracheomalacia, Tracheal Stenosis Following Tracheostomy, Tracheal Reconstruction Surgery

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07665359: Study on the Impact of Decolonization Treatment of Pneumocystis Jirovecii on the Frequency of Acute Exacerbation in COPD

Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine. Phase: NA. Conditions: Chronic Obstructive Pulmonary Disease (COPD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT05735080: Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

Sponsor: Incyclix Bio. Phase: PHASE1. Conditions: Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Ovarian Cancer, CCNE1 Amplification, Solid Tumor, Advanced Cancer, Metastatic Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07235280: Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma

Sponsor: Jonsson Comprehensive Cancer Center. Phase: EARLY_PHASE1. Conditions: Lung Adenocarcinoma, Stage IA1 Lung Cancer American Joint Committee on Cancer (AJCC) v8, Stage IA2 Lung Cancer AJCC v8, Stage IA3 Lung Cancer AJCC v8, Lung Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05638880: Clinical Study to Evaluate the Possible Efficacy and Safety of Levocetirizine in Patients With Diabetic Kidney Disease

Sponsor: Mostafa Bahaa. Phase: PHASE2. Conditions: Diabetic Nephropathies

full page →ctgov ↗
›COMPLETEDphase readoutNCT07259096: Comparison of Sports Anxiety, Sports Injury Anxiety, and Knowledge Levels Regarding Factors Causing Sports Injury in Individuals Who Regularly Engage in Conditioning Work With and Without a History of Injury

Sponsor: Istanbul Saglik Bilimleri University. Phase: . Conditions: People Who Do Regular Conditioning Work

full page →ctgov ↗
›RECRUITINGphase readoutNCT05081596: A Primary Care-Based Psychosocial Intervention To Improve Cognitive & Depression Outcomes in Older Adults With MCI & Early Stage AD

Sponsor: Weill Medical College of Cornell University. Phase: NA. Conditions: Depression, Pain, Cognitive Impairment

full page →ctgov ↗
›RECRUITINGphase readoutNCT07693296: Type 2 Diabetes Mellitus and Downhill Aerobic Exercise Training

Sponsor: Acibadem University. Phase: NA. Conditions: Diabete Type 2, Aerobic Exercise, Walking

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07147582: Effect of Transcranial Alternating Current Stimulation on Sleep Disorder and Anxiety in Elderly Population

Sponsor: Cairo University. Phase: NA. Conditions: Chronic Sleep Disorders, Anxiety Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT06564324: A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients

Sponsor: Nuvation Bio Inc.. Phase: PHASE3. Conditions: Non Small Cell Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06483659: Intravenous Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy

Sponsor: Brigham and Women's Hospital. Phase: PHASE2. Conditions: Postoperative Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07583459: Efficacy of Center-based Childcare to Mitigate Unhealthy Weight Gain in Preschoolers From Low-income Households During the Summer

Sponsor: University of South Carolina. Phase: NA. Conditions: Obesity & Overweight

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07704359: Antibiotics After Incision and Drainage to Prevent Fistula Formation After First Episode of Perianal Abscess

Sponsor: University of Illinois at Chicago. Phase: PHASE4. Conditions: Perianal Abscess, Anal Fistula

full page →ctgov ↗
›COMPLETEDphase readoutNCT05384080: A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Poland

Sponsor: Takeda. Phase: . Conditions: Inflammatory Bowel Disease (IBD), Crohn's Disease, Ulcerative Colitis

full page →ctgov ↗
›COMPLETEDphase readoutNCT06336980: Creating Welcoming Faith Communities for People With Serious Mental Illnesses

Sponsor: Temple University. Phase: NA. Conditions: Other

full page →ctgov ↗
›COMPLETEDphase readoutNCT04993079: Clotild® Smart Guidewire System (CSGS) Evaluation in EndovascUlar Thrombectomy Procedure

Sponsor: Sensome. Phase: NA. Conditions: Stroke

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07539779: Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With Moderate to Severe Myelofibrosis

Sponsor: Nanfang Hospital, Southern Medical University. Phase: PHASE2. Conditions: Luspatercept, Poor Erythroid Engraftment, Hematological Malignancies, Myelofibrosis (MF)

full page →ctgov ↗
›COMPLETEDphase readoutNCT04939896: Study on the Trajectories of Rehabilitation Compliance in Stroke Patients

Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine. Phase: . Conditions: Stroke, Acute

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07670962: Blood-Based Minimal Residual Disease in Advanced Epithelial Ovarian Cancer After 1st Line Therapy

Sponsor: Asan Medical Center. Phase: . Conditions: Ovarian Neoplasms, Carcinoma, Ovarian Epithelial, Ovarian Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07702396: Efficacy of 12 Weeks Versus 24 Weeks Treatment of Directly Acting Antiviral Therapy in Patients With Hepatitis C Related Chronic Liver Disease

Sponsor: Indus Hospital and Health Network. Phase: NA. Conditions: Heptatitis C

full page →ctgov ↗
← prev
page 175 of 178
next →